Oil & Gas Exploration & Production
Compare Stocks
5 / 10Stock Comparison
NOG vs XOM vs CVX vs COP vs DVN
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Oil & Gas Exploration & Production
Oil & Gas Exploration & Production
NOG vs XOM vs CVX vs COP vs DVN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Integrated | Oil & Gas Integrated | Oil & Gas Exploration & Production | Oil & Gas Exploration & Production |
| Market Cap | $2.53B | $620.85B | $364.18B | $140.02B | $28.19B |
| Revenue (TTM) | $2.06B | $323.90B | $184.43B | $58.31B | $12.24B |
| Net Income (TTM) | $-623M | $28.84B | $12.30B | $7.32B | $2.15B |
| Gross Margin | 30.6% | 21.7% | 30.4% | 29.2% | 21.8% |
| Operating Margin | 26.0% | 10.5% | 9.0% | 18.3% | 18.9% |
| Forward P/E | 6.8x | 14.8x | 15.0x | 13.3x | 8.6x |
| Total Debt | $2.40B | $43.54B | $46.74B | $23.44B | $8.78B |
| Cash & Equiv. | $14M | $10.68B | $6.47B | $6.50B | $1.43B |
NOG vs XOM vs CVX vs COP vs DVN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Northern Oil and Ga… (NOG) | 100 | 307.3 | +207.3% |
| Exxon Mobil Corpora… (XOM) | 100 | 322.2 | +222.2% |
| Chevron Corporation (CVX) | 100 | 199.0 | +99.0% |
| ConocoPhillips (COP) | 100 | 272.4 | +172.4% |
| Devon Energy Corpor… (DVN) | 100 | 419.6 | +319.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NOG vs XOM vs CVX vs COP vs DVN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NOG is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 5 yrs, beta 0.60, yield 7.3%
- Lower P/E (6.8x vs 8.6x)
- 7.3% yield, 5-year raise streak, vs XOM's 2.7%
XOM plays a supporting role in this comparison — it may shine differently against other peers.
CVX lags the leaders in this set but could rank higher in a more targeted comparison.
COP is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 233.4% 10Y total return vs XOM's 105.0%
- Lower volatility, beta 0.08, Low D/E 36.4%, current ratio 1.30x
- Beta 0.08, yield 2.8%, current ratio 1.30x
DVN carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 10.0%, EPS growth -8.1%, 3Y rev CAGR -4.8%
- 10.0% revenue growth vs CVX's -4.6%
- 17.6% margin vs NOG's -30.3%
- Beta 0.05 vs NOG's 0.60, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.0% revenue growth vs CVX's -4.6% | |
| Value | Lower P/E (6.8x vs 8.6x) | |
| Quality / Margins | 17.6% margin vs NOG's -30.3% | |
| Stability / Safety | Beta 0.05 vs NOG's 0.60, lower leverage | |
| Dividends | 7.3% yield, 5-year raise streak, vs XOM's 2.7% | |
| Momentum (1Y) | +52.9% vs NOG's +5.3% | |
| Efficiency (ROA) | 9.1% ROA vs NOG's -11.3%, ROIC 12.3% vs 10.0% |
NOG vs XOM vs CVX vs COP vs DVN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NOG vs XOM vs CVX vs COP vs DVN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NOG leads in 1 of 6 categories
DVN leads 1 • XOM leads 1 • CVX leads 0 • COP leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — NOG and XOM each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 157.3x NOG's $2.1B. DVN is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to NOG's -30.3%. On growth, XOM holds the edge at -1.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.1B | $323.9B | $184.4B | $58.3B | $12.2B |
| EBITDAEarnings before interest/tax | $1.3B | $59.9B | $37.1B | $22.4B | $5.0B |
| Net IncomeAfter-tax profit | -$623M | $28.8B | $12.3B | $7.3B | $2.1B |
| Free Cash FlowCash after capex | -$115M | $23.6B | $16.2B | $18.3B | $2.1B |
| Gross MarginGross profit ÷ Revenue | +30.6% | +21.7% | +30.4% | +29.2% | +21.8% |
| Operating MarginEBIT ÷ Revenue | +26.0% | +10.5% | +9.0% | +18.3% | +18.9% |
| Net MarginNet income ÷ Revenue | -30.3% | +8.9% | +6.7% | +12.6% | +17.6% |
| FCF MarginFCF ÷ Revenue | -5.6% | +7.3% | +8.8% | +31.4% | +16.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -6.2% | -1.3% | -5.3% | -2.5% | -99.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.8% | -11.0% | -24.5% | -20.2% | -100.0% |
Valuation Metrics
NOG leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 10.8x trailing earnings, DVN trades at a 82% valuation discount to NOG's 61.4x P/E. On an enterprise value basis, NOG's 3.4x EV/EBITDA is more attractive than XOM's 10.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.5B | $620.8B | $364.2B | $140.0B | $28.2B |
| Enterprise ValueMkt cap + debt − cash | $4.9B | $653.7B | $404.5B | $157.0B | $35.5B |
| Trailing P/EPrice ÷ TTM EPS | 61.38x | 21.86x | 27.53x | 18.09x | 10.80x |
| Forward P/EPrice ÷ next-FY EPS est. | 6.80x | 14.79x | 15.02x | 13.29x | 8.62x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 3.44x | 10.91x | 10.89x | 6.77x | 4.79x |
| Price / SalesMarket cap ÷ Revenue | 1.21x | 1.92x | 1.97x | 2.38x | 1.65x |
| Price / BookPrice ÷ Book value/share | 1.12x | 2.37x | 1.76x | 2.23x | 1.84x |
| Price / FCFMarket cap ÷ FCF | 10.02x | 26.29x | 21.95x | 8.35x | 9.04x |
Profitability & Efficiency
DVN leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
DVN delivers a 18.6% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-29 for NOG. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to NOG's 1.13x. On the Piotroski fundamental quality scale (0–9), NOG scores 6/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -29.1% | +10.7% | +7.2% | +11.3% | +18.6% |
| ROA (TTM)Return on assets | -11.3% | +6.4% | +4.2% | +6.0% | +9.1% |
| ROICReturn on invested capital | +10.0% | +8.6% | +6.2% | +10.4% | +12.3% |
| ROCEReturn on capital employed | +12.4% | +8.9% | +6.6% | +10.4% | +13.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.13x | 0.16x | 0.24x | 0.36x | 0.57x |
| Net DebtTotal debt minus cash | $2.4B | $32.9B | $40.3B | $16.9B | $7.3B |
| Cash & Equiv.Liquid assets | $14M | $10.7B | $6.5B | $6.5B | $1.4B |
| Total DebtShort + long-term debt | $2.4B | $43.5B | $46.7B | $23.4B | $8.8B |
| Interest CoverageEBIT ÷ Interest expense | 0.94x | 69.44x | 17.22x | 9.42x | 7.98x |
Total Returns (Dividends Reinvested)
XOM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XOM five years ago would be worth $26,464 today (with dividends reinvested), compared to $18,177 for NOG. Over the past 12 months, DVN leads with a +52.9% total return vs NOG's +5.3%. The 3-year compound annual growth rate (CAGR) favors XOM at 13.2% vs NOG's -3.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +10.8% | +20.3% | +18.2% | +19.7% | +20.4% |
| 1-Year ReturnPast 12 months | +5.3% | +43.9% | +39.5% | +34.7% | +52.9% |
| 3-Year ReturnCumulative with dividends | -9.4% | +44.9% | +26.7% | +23.7% | -2.0% |
| 5-Year ReturnCumulative with dividends | +81.8% | +164.6% | +94.0% | +131.9% | +120.1% |
| 10-Year ReturnCumulative with dividends | -34.4% | +105.0% | +135.8% | +233.4% | +99.0% |
| CAGR (3Y)Annualised 3-year return | -3.3% | +13.2% | +8.2% | +7.3% | -0.7% |
Risk & Volatility
Evenly matched — XOM and DVN each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than NOG's 0.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DVN currently trades 86.0% from its 52-week high vs NOG's 73.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.60x | -0.15x | -0.05x | 0.08x | 0.05x |
| 52-Week HighHighest price in past year | $32.62 | $176.41 | $214.71 | $135.87 | $52.71 |
| 52-Week LowLowest price in past year | $20.18 | $101.19 | $133.77 | $84.28 | $29.70 |
| % of 52W HighCurrent price vs 52-week peak | +73.4% | +83.0% | +85.0% | +84.6% | +86.0% |
| RSI (14)Momentum oscillator 0–100 | 37.3 | 42.4 | 42.1 | 43.4 | 43.5 |
| Avg Volume (50D)Average daily shares traded | 2.7M | 18.9M | 11.0M | 9.6M | 15.3M |
Analyst Outlook
Evenly matched — NOG and XOM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NOG as "Buy", XOM as "Hold", CVX as "Buy", COP as "Buy", DVN as "Buy". Consensus price targets imply 21.1% upside for NOG (target: $29) vs 4.6% for CVX (target: $191). For income investors, NOG offers the higher dividend yield at 7.29% vs DVN's 2.17%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $29.00 | $160.43 | $190.93 | $127.07 | $53.78 |
| # AnalystsCovering analysts | 13 | 55 | 53 | 52 | 64 |
| Dividend YieldAnnual dividend ÷ price | +7.3% | +2.7% | +3.8% | +2.8% | +2.2% |
| Dividend StreakConsecutive years of raises | 5 | 26 | 8 | 1 | 0 |
| Dividend / ShareAnnual DPS | $1.75 | $4.00 | $6.87 | $3.19 | $0.98 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.3% | +3.3% | +3.3% | +3.6% | +3.7% |
NOG leads in 1 of 6 categories (Valuation Metrics). DVN leads in 1 (Profitability & Efficiency). 3 tied.
NOG vs XOM vs CVX vs COP vs DVN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NOG or XOM or CVX or COP or DVN a better buy right now?
For growth investors, Devon Energy Corporation (DVN) is the stronger pick with 10.
0% revenue growth year-over-year, versus -4. 6% for Chevron Corporation (CVX). Devon Energy Corporation (DVN) offers the better valuation at 10. 8x trailing P/E (8. 6x forward), making it the more compelling value choice. Analysts rate Northern Oil and Gas, Inc. (NOG) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NOG or XOM or CVX or COP or DVN?
On trailing P/E, Devon Energy Corporation (DVN) is the cheapest at 10.
8x versus Northern Oil and Gas, Inc. at 61. 4x. On forward P/E, Northern Oil and Gas, Inc. is actually cheaper at 6. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — NOG or XOM or CVX or COP or DVN?
Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +164.
6%, compared to +81. 8% for Northern Oil and Gas, Inc. (NOG). Over 10 years, the gap is even starker: COP returned +233. 4% versus NOG's -34. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NOG or XOM or CVX or COP or DVN?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus Northern Oil and Gas, Inc. 's 0. 60β — meaning NOG is approximately -509% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 113% for Northern Oil and Gas, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NOG or XOM or CVX or COP or DVN?
By revenue growth (latest reported year), Devon Energy Corporation (DVN) is pulling ahead at 10.
0% versus -4. 6% for Chevron Corporation (CVX). On earnings-per-share growth, the picture is similar: Devon Energy Corporation grew EPS -8. 1% year-over-year, compared to -92. 4% for Northern Oil and Gas, Inc.. Over a 3-year CAGR, NOG leads at 1. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NOG or XOM or CVX or COP or DVN?
Devon Energy Corporation (DVN) is the more profitable company, earning 15.
4% net margin versus 1. 9% for Northern Oil and Gas, Inc. — meaning it keeps 15. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NOG leads at 29. 3% versus 9. 0% for CVX. At the gross margin level — before operating expenses — NOG leads at 32. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NOG or XOM or CVX or COP or DVN more undervalued right now?
On forward earnings alone, Northern Oil and Gas, Inc.
(NOG) trades at 6. 8x forward P/E versus 15. 0x for Chevron Corporation — 8. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NOG: 21. 1% to $29. 00.
08Which pays a better dividend — NOG or XOM or CVX or COP or DVN?
All stocks in this comparison pay dividends.
Northern Oil and Gas, Inc. (NOG) offers the highest yield at 7. 3%, versus 2. 2% for Devon Energy Corporation (DVN).
09Is NOG or XOM or CVX or COP or DVN better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +105. 0% 10Y return). Both have compounded well over 10 years (XOM: +105. 0%, NOG: -34. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NOG and XOM and CVX and COP and DVN?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NOG is a small-cap income-oriented stock; XOM is a large-cap quality compounder stock; CVX is a large-cap income-oriented stock; COP is a mid-cap quality compounder stock; DVN is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.